Hints and tips:
...But transplants are limited by the supply of donor organs, and existing LVAD technologies marketed by Abbott Laboratories and Medtronic often lead to complications....
...Abbott Laboratories, Chevron and Gilead Sciences were also among those sharply increasing debt repayments....
...SoftBank founder predicts WeWork V for Victory Masayoshi Son admitted today he had turned a “blind eye” to governance lapses at WeWork but promised a “sharp V-shaped recovery” for the shared offices provider...
...Qubits v bytes: how quantum computing works Quantum computing taps into the quirky behaviour of sub-atomic particles, which bend our normal understanding of physics....
...In a paper released last month, OECD economists linked the insufficient diffusion of new technologies to weak overall productivity growth....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...There are plenty of others, including St Jude Medical (acquired by Abbott Laboratories in January of this year), which is currently battling lawsuits relating to vulnerabilities in its implantable cardiac...
...The deal comes at a time of major upheaval in the medical devices industry as large players such as Medtronic, Abbott Laboratories and Johnson & Johnson each try to narrow their focus to compete with smaller...
...“The pitch was always that Amazon is a trade off between rising physical store rental costs and structurally declining technology costs,” he says....
...Shares in St Jude Medical — which Abbott Laboratories agreed to take over for $30bn in April — fell about 5 per cent to $77.82 on Thursday, despite the company denying the security problems....
...Abbott Laboratories, the US pharmaceutical, has agreed to acquire St Jude Medical for an equity value of about $25bn, the first major healthcare deal after a three month slowdown in the merger and acquisition...
...Abbott’s acquisition may also spark a fresh wave of healthcare M&A, with a focus on the technology-focused medical devices sector....
...Abbott Laboratories — a nutrition and medical devices company — this month introduced its first new range of snack bars in more than a decade....
...Other developers of companion diagnostics include Abbott Laboratories, Agilent Technologies, Myriad Genetics and Qiagen....
...Nick Koberstein, division counsel at Abbott Laboratories, the global healthcare company advised by Baker & McKenzie, says: “These tools are critical for my position....
...Google, Facebook, Pfizer and Abbott Laboratories are among the companies that have benefited from what is a legal loophole that exploits the differences between definitions of tax residency in US and Irish...
...The technology-heavy Nasdaq Composite increased 0.56 per cent to 4,440.42. eric.platt@ft.com Twitter: @ericgplatt...
...But the medicine was licensed to Abbott, of which AbbVie used to be part, and CAT was bought by AstraZeneca, creating a case study in how the spoils of drug innovation often land a long way from the laboratories...
...Robotic assistants, driverless cars, connected homes, digital public services, laboratory-grown meat, augmented reality and electric-powered vehicles are just a few of the futuristic technologies elbowing...
...Long-held deals such as the franchise to run Britain’s Docklands Light Railway and the National Physical Laboratory have been lost....
...One of Winter’s own companies, Cambridge Antibody Technologies, which developed Humira, was acquired in 2006 by AstraZeneca, which in turn licensed the drug to Abbott Laboratories....
...Adobe is one of hundreds of technology and pharmaceutical companies, including Apple, Google and Abbott Laboratories, which funnel non-US sales through Ireland to cut their tax bills....
...(Bloomberg, Quartz) “The pace of US bond deals has accelerated sharply in the wake of Hurricane Sandy, with a sale by an arm of Abbott Laboratories, the drug and medical device maker, becoming the single...
...Abbott Laboratories was up 1.5 per cent to $53.25 after saying it would split into two entities, one focused on research and the other selling drugs and medical devices....
...“There is a potential for a bidding war – companies like Siemens, Abbott [Laboratories] and Danaher might be interested,” he added. The shares closed 153p higher at 500p....
International Edition